SEC Form 4 research
| Issuer | NovaBay Pharmaceuticals, Inc. |
|---|---|
| Tickers | NBY, SDEV |
| Reporting owners | 62 |
| Officers and directors | 18 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-05 | 2025-10-16 | Sit Swan | A | 6,000 | $0 | Not reported |
| 2026-11-05 | 2025-10-16 | Freiman Paul E. | A | 6,000 | $0 | Not reported |
| 2026-11-05 | 2025-10-16 | Zheng Yenyou | A | 6,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.